Anika Therapeutics (ANIK) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.79 +0.05%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of ($0.11), $0.13 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $38.95 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- Citi maintains buy ratings on Argentina power firms amid sector shifts
- Freedom Broker Starts Citizens Inc. (CIA) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
